Company news
Tetra Bio-pharma Inc. (OTC:TBPMQ) news
Tetra Bio-pharma Inc. news releases on 6ix. Latest, Apr 29, 2019: Tetra Bio-Pharma and Altus Formulation Sign Joint Venture Agreement for Cannabinoid Drug…
Press releases — page 4
Tetra Bio-Pharma and Altus Formulation Sign Joint Venture Agreement for Cannabinoid Drug Product Development
April 29, 2019
Tetra Bio-Pharma Shareholders Approve the Acquisition of Panag Pharma
April 18, 2019
Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer
April 11, 2019
Tetra Bio-Pharma Resumes its Phase 3 Clinical Trial Program
April 9, 2019
Tetra Bio-Pharma Announces Employment Contract Renewal of CEO Guy Chamberland
April 1, 2019
Tetra Bio-Pharma to File PPP001 With the European Medicines Agency
March 26, 2019
Tetra Bio-Pharma Names Vice-President, Clinical Programs and Medical Affairs to Its Leadership Team
March 6, 2019
Tetra Bio-Pharma and Santé Cannabis Announce Completion of the First Phase 2 Cannabis Oil Trial in Cancer and Non-Cancer Patients
March 4, 2019
Two in Three (65%) Canadians Would Take a Drug Containing Cannabis if Prescribed by a Doctor and Covered by Insurance
February 26, 2019
The Hemp Energy Drink arrives in store!
February 18, 2019
Tetra Bio-Pharma Provides Update on its Neuropathic and Chronic Pain Drug Development Program
February 12, 2019